280 related articles for article (PubMed ID: 23757108)
1. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.
Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A
Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiological and Therapeutic Considerations for Non-Neurogenic Lower Urinary Tract Dysfunction in Children.
Kakizaki H; Kita M; Watanabe M; Wada N
Low Urin Tract Symptoms; 2016 May; 8(2):75-85. PubMed ID: 27111618
[TBL] [Abstract][Full Text] [Related]
3. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
4. Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases.
Wiedemann A; Kaeder M; Greulich W; Lax H; Priebel J; Kirschner-Hermanns R; Füsgen I
World J Urol; 2013 Feb; 31(1):229-33. PubMed ID: 22227822
[TBL] [Abstract][Full Text] [Related]
5. Lower urinary tract dysfunction in MS: management in the community.
Panicker J; Haslam C
Br J Community Nurs; 2009 Nov; 14(11):474, 476, 478-80. PubMed ID: 20166471
[TBL] [Abstract][Full Text] [Related]
6. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis.
Zecca C; Panicari L; Disanto G; Maino P; Singh A; Digesu GA; Gobbi C
Int Urogynecol J; 2016 Apr; 27(4):521-7. PubMed ID: 26245726
[TBL] [Abstract][Full Text] [Related]
7. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
[TBL] [Abstract][Full Text] [Related]
8. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
[TBL] [Abstract][Full Text] [Related]
9. Videourodynamic analysis of the urethral sphincter overactivity and the poor relaxing pelvic floor muscles in women with voiding dysfunction.
Peng CH; Chen SF; Kuo HC
Neurourol Urodyn; 2017 Nov; 36(8):2169-2175. PubMed ID: 28346720
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients.
Sacco R; Maino P; Koetsier E; Disanto G; Renard J; Digesu A; Gobbi C; Zecca C
Eur J Neurol; 2024 Feb; 31(2):e16146. PubMed ID: 37975785
[TBL] [Abstract][Full Text] [Related]
11. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
[TBL] [Abstract][Full Text] [Related]
12. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis.
Lúcio AC; Campos RM; Perissinotto MC; Miyaoka R; Damasceno BP; D'ancona CA
Neurourol Urodyn; 2010 Nov; 29(8):1410-3. PubMed ID: 20976816
[TBL] [Abstract][Full Text] [Related]
13. Management of neurogenic bladder in patients with multiple sclerosis.
Phé V; Chartier-Kastler E; Panicker JN
Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
[TBL] [Abstract][Full Text] [Related]
14. Urodynamics in patients with multiple sclerosis: A consensus statement from a urodynamic experts working group.
Averbeck MA; Iacovelli V; Panicker J; Schurch B; Finazzi Agrò E
Neurourol Urodyn; 2020 Jan; 39(1):73-82. PubMed ID: 31746485
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Sand PK; Sand RI
Dis Mon; 2013 Jul; 59(7):261-8. PubMed ID: 23786660
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis--a double blind, placebo controlled, randomised clinical trial.
McClurg D; Ashe RG; Lowe-Strong AS
Neurourol Urodyn; 2008; 27(3):231-7. PubMed ID: 17705160
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
Zachariou A; Filiponi M; Baltogiannis D; Giannakis J; Dimitriadis F; Tsounapi P; Takenaka A; Sofikitis N
Can J Urol; 2017 Dec; 24(6):9107-9113. PubMed ID: 29260636
[TBL] [Abstract][Full Text] [Related]
18. The effect of cortical versus sacral repetitive magnetic stimulation on lower urinary tract dysfunction in patients with multiple sclerosis.
El-Habashy H; Nada MM; Maher EA; Shamloul R; Maged M; Abdelazim MS
Acta Neurol Belg; 2020 Feb; 120(1):141-147. PubMed ID: 31828602
[TBL] [Abstract][Full Text] [Related]
19. Urological dysfunction in patients with hereditary spastic paraplegia.
Joussain C; Levy J; Charlanes A; Even A; Falcou L; Chartier Kastler E; Denys P
Neurourol Urodyn; 2019 Apr; 38(4):1081-1085. PubMed ID: 30848841
[TBL] [Abstract][Full Text] [Related]
20. Lower urinary tract dysfunction in patients with multiple sclerosis.
Panicker JN; Fowler CJ
Handb Clin Neurol; 2015; 130():371-81. PubMed ID: 26003255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
